Loading...
Docoh

Health Catalyst (HCAT)

Employees
Data from SEC filings
CEO pay ratio
CEO Salary
Median Employee Salary
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
ESG term mentions
In last year of SEC filings
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM


On June 10, 2021, Health Catalyst, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). The Company's stockholders voted on four proposals at the Annual Meeting, each of which is described in greater detail in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 27, 2021. The number of shares of the Company's common stock entitled to vote at the Annual Meeting was 44,475,560. The number of shares of the Company's common stock present or represented by valid proxy at the Annual Meeting was 38,626,363. The final voting results with respect to each such proposal are set forth below.


Proposal 1 – Election of Directors
The Company's stockholders elected each of the three persons named below to serve as a Class II director of the Company to serve a three-year term ending at the 2024 annual meeting or until his or her successor is elected and qualified. The results of such vote were as follows:


Director NameVotes ForVotes WithheldBroker Non-Votes
Daniel Burton27,351,4546,595,7374,679,172
John A. Kane25,938,3778,008,8144,679,172
Julie Larson-Green27,115,5166,831,6754,679,172





Proposal 2 – Ratification of Appointment of Independent Registered Public Accounting Firm
The Company's stockholders ratified the appointment of Ernst & Young LLP to perform the audit of the Company’s consolidated financial statements for the fiscal year ending December 31, 2021. The results of such vote were as follows:


Votes ForVotes AgainstAbstentions
38,215,462403,8027,099





Proposal 3 – To approve, on an advisory, non-binding basis, the compensation of the Company’s named executive officers
The stockholders approved the non-binding, advisory proposal to approve the compensation of the Company’s named executive officers. The results of such vote were as follows:
Votes ForVotes AgainstAbstentionsBroker Non-Votes
20,529,21012,972,753445,2284,679,172



Proposal 4 – To vote to recommend, on an advisory, non-binding basis, the frequency of future advisory, non-binding votes on the compensation of the Company’s named executive officers
The stockholders approved holding the advisory, non-binding vote on the compensation of the Company’s named executive officers each year. The results of such vote were as follows:
1 Year2 Years3 YearsAbstainBroker Non-Votes
32,548,7975,4571,123,410269,5274,679,172